🔗 Share this article

While America continues making historic revisions to its vaccination recommendations, one figure appears in a surprising turn: Dr. Tracy Beth Høeg, a Danish American sports medicine doctor and epidemiologist who rose to prominence by casting doubt on COVID-19 vaccinations in the pandemic and has zeroed in on alleged deaths following COVID-19 vaccination in her brief tenure at the US Food and Drug Administration (FDA).

Scheduled Changes to Childhood Immunization Program

Agency leaders had intended to announce radical changes to the childhood vaccine schedule earlier this month, bringing the US with the Danish vaccine program, it is understood – a major change that would place the US out of step with much of the international standard with no evidence for improved outcomes. The planned update has been pushed back until the next year.

Instead of the director of the vaccine center, Høeg is scheduled to speak at the gathering. She was recently named acting director of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth person to run the center this year.

Consolidating Power at the Agency

Høeg's temporary position might represent a tighter collaboration between the drug and biologics branches as Dr. Høeg and Prasad solidify control at the FDA – and it suggests a greater focus upon rolling back previously authorized vaccines at the FDA.

Dr. Høeg has repeatedly called for halting some pediatric immunization guidelines in the US to become more similar to Denmark, a country with comprehensive healthcare and a population roughly the population of the state of Wisconsin.

To date comments, she has kept her attention on vaccines – usually the responsibility of Dr. Prasad, chief of the FDA’s CBER – rather than medication approval.

Questions Over Expertise

Høeg has little discernible track record in medication creation, approval processes or leadership, which has been customary for previous directors of the CBER. She has worked at the FDA as a top consultant to the FDA chief and CBER since March.

“It seems she lacks to have any of the qualifications” for overseeing the drug-regulation department, stated Dr. Jonathan Howard. “She’s never run a scientific study. She has no expertise in leading a sizeable institution. She is not an expert in industry regulation.”

Former commissioners of CBER would “understand legal statutes and the research of medication creation”, said Janet Woodcock. “Clearly, she has not acquired the kind of background that prior appointees who headed the center have had.”

CDER has an enormous portfolio at the agency, Woodcock emphasized.

“The public just focuses on the novel medication approvals, but the generic program authorizes a multitude of generic medications. There is also a biosimilars division, non-prescription drug unit and more, and every single one need to be looked after,” Dr. Woodcock noted. “The area you don’t keep your eye on, that is the part that I always told people is going to bite you.”

Furthermore, a major management component to the job, which oversees over 5,000 employees. “It is a huge administrative position, if you perform it correctly,” the former official said.

Response and Contentious Initiatives

In response to questions about Dr. Høeg's qualifications and whether this selection represents greater collaboration among agency officials on vaccines, a representative responded that the “concerns stem from incorrect premises”.

“Her resume is consistent with the duties of her role,” the official said, pointing to the months Høeg spent advising the agency head on “medication safety and oversight research, including predictive safety algorithms and shot safety tracking”.

As acting director, Dr. Høeg takes over the commissioner’s controversial expedited review system, a controversial expedited drug-approval program that reportedly worried her predecessors. “How are these therapies being picked for this expedited pathway? Who is making the calls?” Dr. Howard said. “There is a lot of secrecy occurring at the regulatory body right now.”

Broadly speaking, he stated, “the Food and Drug Administration seems to be moving towards less stringent regulations of all drugs, aside from vaccines.”

Documented Past Work on Vaccines

With immunizations, Dr. Høeg has a clearer, if problematic, past, critics observe. She released a study using unconfirmed public submissions to determine the rate of myocarditis following Covid vaccination. She consulted for the state of Florida top health official Dr. Joseph Ladapo, who reportedly have changed statistics to imply COVID-19 vaccinations are pose a greater threat than they are.

Part of her “policy goals” for the current federal leadership featured changing guidelines for recently developed shots and halting “non-essential” immunizations, she remarked after the election on a podcast. At the agency, Høeg has reportedly floated the idea of preventing adolescent males from getting Covid vaccinations.

“She is an all-around ideologue who begins with her beliefs and works backwards to accommodate the science in a very deceptive, fraudulent manner,” Dr. Howard said.

Gaining Influence and a “Revenge Tour”

Dr. Høeg aligned with fellow contrarians, {like|